With several drugs in use that inhibit the hepatitis B virus polymerases (nucleos(t)ide analogues (or NUCs)), some argue that new direct-acting antiviral drugs, and new NUCs in particular ...

Sharing injection supplies increases the risk of bloodborne infections such as HIV infection, hepatitis B virus infection, and hepatitis C virus infection. In addition, adulterants in drugs can ...

However, with the widespread use of PD-1 inhibitors, there are increasing reports of immune-related adverse events (irAEs) in clinical practice, with immune-related hepatitis (IRH) being particularly ...

Canadian Medical Association Journal (CMAJ), Canadian Guideline on HIV Pre-exposure Prophylaxis and Non-occupational Post-exposure Prophylaxis Canadian AIDS Treatment Information Exchange (CATIE) ...

Methods: An aptamer-based (7,289 marker) proteomic assay coupled with traditional serology was leveraged to generate a comprehensive evaluation of systemic responsiveness in 64 and 68 healthy ...

Gregory Hislop Liver cancer control programs for Chinese immigrant communities should include HBV serologic testing to identify chronically infected individuals (who may benefit from monitoring ...

Hepatitis B (sometimes referred to as hep B) is a liver infection caused by the hepatitis B virus (HBV). It typically causes symptoms like stomach pain, dark urine, fatigue, fever, jaundice (yellowing ...

For patients at high risk of hepatitis B reactivation, AGA recommends preventive antiviral medication. Reactivated HBV can lead to liver damage, hospitalization, and even death.

ANA, SMA, or anti-LKM1 ≥ 1:80 in adults and ≥ 1:20 in children; no AMA Hypergammaglobulinemia of any degree ANA, SMA or anti-LKM1 ≥ 1:40 in adults; other autoantibodies Interface hepatitis ...